San Francisco, CA, United States of America

Cynthia Honchell

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Spotlight on Inventor Cynthia Honchell: Pioneer in Cancer Diagnosis and Treatment

Introduction

Cynthia Honchell, a renowned innovator hailing from San Francisco, CA, is making waves in the field of cancer diagnosis and treatment. With a focus on methods and compositions related to colorectal cancers, she has successfully secured a patent that showcases her expertise and dedication to advancing healthcare solutions.

Latest Patents

Cynthia Honchell's notable patent revolves around "Methods and compositions for the diagnosis and treatment of cancer," specifically targeting colorectal cancers associated with amplification or overexpression of the FGFR2 gene. This groundbreaking approach underscores her commitment to precision medicine and personalized healthcare interventions.

Career Highlights

Currently affiliated with Genentech, Inc., a powerhouse in the biotechnology industry, Cynthia Honchell brings her expertise to a dynamic and innovative environment. At Genentech, she continues to push the boundaries of scientific discovery, contributing significantly to the development of novel therapies for cancer patients worldwide.

Collaborations

In her pursuit of excellence, Cynthia Honchell collaborates closely with esteemed colleagues such as John Chant and Anthony S. Guerrero. Together, they form a formidable team driving forward cutting-edge research and development initiatives aimed at revolutionizing cancer care and improving patient outcomes.

Conclusion

In conclusion, Cynthia Honchell emerges as a trailblazer in the field of cancer research, leveraging her expertise to pioneer advancements in diagnosis and treatment modalities. Through her patent and collaborative efforts, she exemplifies a commitment to innovation that promises to shape the future of oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…